1. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease;Group, International Mesalazine Study;Aliment Pharmacol Therap,1990
2. Oral 5-aminosalicylic acid (Asacol) in the maintenance of Crohn's Disease. The Italian;Prantera, C.; Pallone, F.; Brunetti, G.; Cottone, M.; Migliolo, M.
3. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study;Gendre, J.P.; Mary, J.Y.; Florent, C.; Modigliani, R.; Colombel, J.F.; Soule, J.C.;Gastroenterology,1993
4. Oral 5-aminosalycilic acid (5-ASA) in the prevention of early relapse of Crohn's disease. Interim analysis of a multicenter double blind randomised placebo-controlled trial;R, De Franchis; C, Brignola; M, Del Piano; P, Omodei; A, Pera; T, Ranzi;Gastroenterology,1994
5. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI);Best, W.R.; Becktel, J.M.; Singleton, J.W.;Gastroenterology,1979